DAPA - Egypt Study

CompletedOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

March 9, 2019

Primary Completion Date

March 30, 2020

Study Completion Date

March 30, 2020

Conditions
Type-2 Diabetes
Trial Locations (21)

D1690R00050

Research Site, Behira

D1690R00049

Research Site, El Rehab

Research Site, Fiasal

Research Site, Haram

Research Site, Madīnat an Naşr

Research Site, Manial

Research Site, Mohandesin

Research Site, Nozha

Research Site, Sharkia

Research Site, West Lbalad

Research Site, Al Mansurah

Research Site, Alexandria

Research Site, Asyut

Research Site, Giza

Research Site, Heliopolis

Research Site, Maadi

Research Site, Mohandessin

Research Site, Sohag

Research Site, Tanta

D1690R00051

Research Site, Al Mansurah

D1690R00053

Research Site, Cairo

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY